ALX Oncology Holdings Inc.
ALXO
$1.91
-$0.10-4.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.74% | 41.71% | 21.65% | 27.89% | 34.14% |
| Total Depreciation and Amortization | -21.01% | -28.91% | -29.44% | -31.70% | 224.55% |
| Total Amortization of Deferred Charges | -4.35% | 1.49% | 4.35% | 9.09% | 4.55% |
| Total Other Non-Cash Items | -84.37% | -47.79% | -48.05% | -57.54% | -22.17% |
| Change in Net Operating Assets | 116.17% | -663.88% | 108.44% | 260.67% | -151.08% |
| Cash from Operations | 31.40% | 24.39% | 40.77% | 32.64% | 11.89% |
| Capital Expenditure | 63.83% | 16.67% | 18.33% | 62.42% | 47.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -70.95% | -478.94% | -66.06% | -17.00% | 2,143.03% |
| Cash from Investing | -70.77% | -479.95% | -66.15% | -16.74% | 2,360.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -549.79% | -425.08% | -768.42% | 55.31% | -8.72% |
| Issuance of Common Stock | 613.33% | -- | -51.11% | -99.81% | -98.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -2,644.62% | 266.57% | -100.00% | -100.00% |
| Cash from Financing | 161.71% | 214,661.54% | 106.71% | -163.35% | -100.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -616.23% | 422.19% | -582.53% | 628.87% | -187.88% |